Generic Drugs


Generic Drugs Market Research Reports Analysis and Trends

Publication Single User License (PDF) Price
Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Date Published: Jun 25 2012
Generics in the Antivirals Market to 2018 Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth” report describes generic market in antiviral therapeutics. This report covers antiviral therapeutics including HIV therapeutics, Hepatitis therapeutics, Herpes therapeutics, CMV therapeutics and Influenza therapeutics.
Generics in the Antivirals Market was estimated at $4.2 billion in 2010 and is expected to reach to $9.2 billion in 2018.
 
$3,500.00
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Date Published: Dec 14 2012
$3,500.00
Generic and innovative drugs market in Central Europe 2013

Generic and innovative drugs market in Central Europe 2013

Date Published: May 1 2013

Compare generic & innovative drug markets across Central Europe.
Report studies reimbursement regulations; forecasts market growth for 2013-2015.

$3,500.00
Generic and innovative drugs market in Central Europe 2014

Generic and innovative drugs market in Central Europe 2014, Comparative analysis, reimbursement policies and development forecasts for 2014-2018

Date Published: Jun 12 2014
Report provides comparative analyses, forecasts for development to 2018:
Key Questions Answerd:
  • What is the value of the Central European generic and innovative drug market?
$3,500.00
Generic and innovative drugs market in CIS countries 2013 : Russia, Ukraine and Kazakhstan

Generic and innovative drugs market in CIS countries 2013 : Russia, Ukraine and Kazakhstan

Date Published: Apr 1 2013

Keep current with the changing CIS generic and innovative drug segments.
Survey conditions and track market development in Russian Ukraine and Kazakhstan to 2015.
Generic and innovative drug segments in CIS countries have played a huge role in supporting the pharmaceutical industry. Meanwhile, the effects of programmes such as Russia’s Pharma 2020, Kazakhstan’s GMP initiative and Ukraine’s updated reimbursement structure are visible in the marketplace.

$2,800.00
Generic and innovative drugs market in CIS countries 2014: Russia, Ukraine and Kazakhstan Development forecasts for 2014-2019

Generic and innovative drugs market in CIS countries 2014: Russia, Ukraine and Kazakhstan Development forecasts for 2014-2019

Date Published: Jul 24 2014
Compare and analyse generic and innovative drug markets in CIS countries.Report provides comprehensive market data, forecasts for development to 2019. Now you can explore the prospects for growth in the generic and innovative drug markets in Russia, Ukraine and Kazakhstan quickly, conveniently and economically. Discover the value, recent growth and forecasts for expansion in both segments of each market, in each country, and gain valuable and usable information that contributes to a solid working knowledge of this market and its many complex issues.
$2,800.00
Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines

Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines

Date Published: Aug 1 2014
PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 333 tables & figures. The Indian pharmaceutical market (IPM) is presented as follows:
 
$2,000.00
Generic and innovative drugs market in Ukraine 2014: Development forecasts for 2014-2019

Generic and innovative drugs market in Ukraine 2014: Development forecasts for 2014-2019

Date Published: Aug 15 2014
Explore key issues on the Ukrainian market for generic and innovative drugs. Report forecasts market development, analyses regulatory changes to 2019. 
  • Which are the most influential manufacturers of generic and innovative drugs for the Ukrainian market?
  • What reimbursement policies will most likely influence this market in the near future?
$1,330.00
Generic and innovative drugs market in Russia 2014: Development forecasts for 2014-2019

Generic and innovative drugs market in Russia 2014: Development forecasts for 2014-2019

Date Published: Aug 15 2014
What’s ahead for Russia’s generic and innovative drugs market? Report reveals market value, forecasts for development 2014-2019. 
  • How do physicians view the expanding selection of generics and innovative treatments available in Russia?
  • Which company manufactures the largest quantity of generic drugs and innovative treatments for this market?
$1,330.00
Anti-Diabetic Pharmaceuticals Market in India 2011

Anti-Diabetic Pharmaceuticals Market in India 2011

Date Published: Aug 25 2011

Anti-diabetic pharmaceuticals market in India is one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world after China, the Indian market is characterized by a huge demand for anti-diabetic drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of diabetes cases, introduction of newer and better drugs, increasing aging population and introduction of diabetes insurance policies is helping the market to grow.

$795.00
Oncology Pharmaceuticals Market in India 2011

Oncology Pharmaceuticals Market in India 2011

Date Published: Aug 4 2011

Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players.

$795.00

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data